Sort by
Refine Your Search
-
, transportation, and energy. Our work generally focuses on behavior modeling, instrumentation, and the study of the durability of the structures or products in question. A significant part of our research focuses
-
innovative porous solid nanoparticles capable of capturing and degrading model toxic agents of the NRBC type. The properties of these materials ensure (i) shaping efficiency (deposition on the fibre), (ii
-
biochemistry, structural biology, proteomics, novel detection and screening methods and pre-clinical models for wound healing and regenerative medicine applications. REMOD-HEALING is a Doctoral Network funded by
-
consortium composed of specialists in signal processing (i3S Laboratory), computational cardiac modeling (Karlsruhe Institute of Technology, Germany) and interventional cardiology (Nice Pasteur University
-
the development and activity of human beige adipose tissue. We will use a human beige adipose tissue organoid model recently developed by the team from cells derived from the vascular stromal fraction of human
-
environment featuring a wide range of research activities, including QM/MM simulations, ionic liquid simulations, and excited-state characterization. The aim of this PhD thesis is the atomistic modeling
-
also collaborate with the “Cognition Perception Usages” team at LISN, led by Jean-Claude MARTIN, who specialises in psychological theories and models of motivation, personality, and social interactions
-
and optimize specific functions. The ICMCB carries out fundamental research on model materials and/or materials with potential applications. The ICMCB is a UMR with an average of 280 agents (permanent
-
phenomena (nanoscience and size-dependent fundamental properties) Soft matter and physics–biology interfaces (complex systems, living tissues, liquid crystals, foams, polymers, granular matter). The PhD will
-
that will bring us closer to the cellular context. The PhD student will use a combination of biochemical and structural biology methods: reconstitution of ribonucleoprotein complexes from cell extracts and/or